Quliang Zhong, Kehua Jiang, Facai Zhang, Yuan Tian, Jiang Gu, Tao Li, Xulong Chen, Jianjun Yang, Fa Sun: Exploring the correlation of glycolysis-related chondroitin polymerizing factor (CHPF) with clinical characteristics, immune infiltration, and cuproptosis in bladder cancer. Am J Cancer Res 2023;13(6):2213-2233. (Full text, PDF)
Chaofan Li, Yuxin Hui, Xinyu Wei, Peizhuo Yao, Yiwei Jia, Mengjie Liu, Yusheng Wang, Jia Li, Yifan Cai, Yu Zhang, Zeyao Feng, Yinbin Zhang, Shuqun Zhang, Chong Du: Visualized machine learning models combined with propensity score matching analysis in single PR-positive breast cancer prognosis: a multicenter population-based study. Am J Cancer Res 2023;13(6):2234-2253. (Full text, PDF)
Wei-Ming Chen, Yuan-Yuan Fang, Ping Lin, Jian-Xi Bai, Yi-Fan Fang, Bing Zhang: A novel nomogram for predicting post-recurrence survival in recurrent neuroblastoma patients. Am J Cancer Res 2023;13(6):2254-2268. (Full text, PDF)
Youyu Lin, Wenting Zhong, Qili Lin, Yan Ye, Shengzhao Li, Hui Chen, Hongxia Liu, Luyun Xu, Wei Zhuang, Shaoqing Chen, Yao Lin, Qingshui Wang: SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis. Am J Cancer Res 2023;13(6):2269-2284. (Full text, PDF, Supplementary Tables 1, 2, 3)
Chi-Ping Huang, Hsin-Ling Lu, Chih-Rong Shyr: Anti-tumor activity of intratumoral xenogeneic urothelial cell monotherapy or in combination with chemotherapy in syngeneic murine models of bladder cancer. Am J Cancer Res 2023;13(6):2285-2306. (Full text, PDF)
Huailu Tu, Zhuo Zhang, Jingxia Li, Sophia Shi, Max Costa: Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1/FSCN1 pathway. Am J Cancer Res 2023;13(6):2307-2322. (Full text, PDF)
Dafeng Tong, Jie Yuan, Zhaoming Wang, Enda Yu, Jifu E: USP37 promotes angiogenesis and metastasis in colorectal cancer by facilitating β-catenin stability. Am J Cancer Res 2023;13(6):2323-2341. (Full text, PDF)
Ji Song, Yanshi Li, Tao Lu, Min Pan, Zhihai Wang, Chuan Liu, Yang Liao, Guohua Hu: miR-19a mediates the mechanism by which SPHK2 regulates hypopharyngeal squamous cell carcinoma progression through the PI3K/AKT axis. Am J Cancer Res 2023;13(6):2342-2359. (Full text, PDF)
Rujin Xu, Xingyuan Ci, Fang He, Yueqin Chen: Circular RNA hsa_circ_001350 contributes to osteosarcoma progression by regulating microRNA-578/CCR4-NOT transcription complex and subunit 7/Wnt signaling. Am J Cancer Res 2023;13(6):2360-2375. (Full text, PDF)
Luopei Guo, Chunbo Li, Jingjing Guo, Junjun Qiu, Keqin Hua: CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-κB signaling. Am J Cancer Res 2023;13(6):2376-2391. (Full text, PDF)
Xinmu Zhang, Christina Nadolny, Qiwen Chen, Winifer Ali, Syed F Hashmi, Ruitang Deng: Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma. Am J Cancer Res 2023;13(6):2392-2409. (Full text, PDF)
Young Jun Lee, Jin-Hwa Jung, Da-Young Chang, Min Gyeong Kim, Narayan Bashyal, Woo Sup Hwang, Hyun Goo Woo, Sun Ha Paek, Haeyoung Suh-Kim, Sung-Soo Kim: THOC2 expression and its impact on 5-fluorouracil resistance in glioblastoma multiforme. Am J Cancer Res 2023;13(6):2410-2425. (Full text, PDF)
Jiawei Yue, Hui Guo, Peng Xu, Jinhong Ma, Yumin Wu: Activation of the GPR35 on ILC2 drives immunosuppression to promote lung cancer progression. Am J Cancer Res 2023;13(6):2426-2438. (Full text, PDF)
Min Gyeong Kim, Young Jun Lee, Jin-Hwa Jung, Da-Young Chang, Narayan Bashyal, Haeyoung Suh-Kim, Sung-Soo Kim: Enhanced antitumor efficacy of mesenchymal stem cells expressing cytosine deaminase and 5-fluorocytosine combined with α-galactosylceramide in a colon cancer model. Am J Cancer Res 2023;13(6):2439-2451. (Full text, PDF)
Jay Singh, Mercilena Benjamin, Avanish Kumar Pandey, Sarita Kumari, Mohammad Shadab Ali, Jayanth Kumar Palanichamy, Sameer Bakhshi, Amitabh Singh, Deepam Pushpam, Akash Kumar, Rachna Seth, Inder Singh, Pranay Tanwar, Amar Ranjan Singh, Gunjan Sharma, Mohit Arora, Anita Chopra: Prognostic relevance of surface expression of cytokine receptor-like factor 2in pediatric B-lineage acute lymphoblastic leukemia. Am J Cancer Res 2023;13(6):2452-2470. (Full text, PDF)
Yueyang Liu, Weiwei Gong, Konstantina Panoutsopoulou, Thirza Singer-Cornelius, Katharina Augustin, Holger Bronger, Marion Kiechle, Julia Dorn, Andreas Scorilas, Margaritis Avgeris, Viktor Magdolen, Tobias Dreyer: Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer. Am J Cancer Res 2023;13(6):2471-2487. (Full text, PDF)
Lianghao Mao, Pan Jiang, Xuan Lei, Bing Zhang, Xinyu Zhong, Zhengyu Yin, Yongjie Wang, Dapeng Li, Yiming Zhang, Qiping Zheng: The splicing factor proline and glutamine rich promotes the growth of osteosarcoma via the c-Myc signaling pathway. Am J Cancer Res 2023;13(6):2488-2503. (Full text, PDF)
Teona Paresishvili, Merab Janelidze, Zurab Kakabadze: Multifunctional hybrid hydrogel for the prevention of post-surgery tumor recurrence. Am J Cancer Res 2023;13(6):2504-2516. (Full text, PDF)
Yiting Wang, Yufan Sun, Hai Li, Jie Xu: Galectin-8 alters immune microenvironment and promotes tumor progression. Am J Cancer Res 2023;13(6):2517-2529. (Full text, PDF)
Feilong Yang, Wuhuan Xu, Xielin Tang, Qianke Li, Xiaolin Hou, Xuhui Hui: Claudin 4 enhances the malignancy of glioma cells via NNAT/Wnt signaling. Am J Cancer Res 2023;13(6):2530-2539. (Full text, PDF)
Mengran Lang, Leijuan Gan, Shaohua Ren, Ruyu Han, Xiaochen Ma, Guangtao Li, Huikai Li, Ti Zhang, Qiang Wu, Yunlong Cui, Wei Zhang, Feng Fang, Qiang Li, Wei Lu, Tianqiang Song: Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study. Am J Cancer Res 2023;13(6):2540-2553. (Full text, PDF)
Lei Sun, Yue Zhao, Yan Li, Wenshan Zhai, Fang Gao, Qin Yin, Wei Cheng, Zhiping Wang, Yinming Zeng: Effect of continuous subanesthetic esketamine infusion on postoperative fatigue in patients undergoing laparoscopic radical resection for colorectal cancer: a randomized controlled study. Am J Cancer Res 2023;13(6):2554-2563. (Full text, PDF)
Dariusz Uczkowski, Arunabh Sekhri, Shilpi Gupta, Leah Gendler, Krzysztof Misiukiewicz, Miles Levin, Bonni Guerin: Treatment of HER2+ breast cancer: a retrospective of disease prognosis with loss of HER2 amplification on residual disease after neoadjuvant treatment in a community hospital setting. Am J Cancer Res 2023;13(6):2564-2571. (Full text, PDF)
Xiao Yu, Jing-Quan Teng, Jia Chen, Chao Peng, Tong-Rui Guo, Meng-Wei Dong, Xiao-Lu Hao, Kai-Xin Li, Xiang-Xiang Huo, Cui-Cui Ren: ELL associated factor 2 is a potential diagnostic and prognostic indicator: evidence from the in silico and in vitro experiments. Am J Cancer Res 2023;13(6):2572-2587. (Full text, PDF)
Yi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao: High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patients. Am J Cancer Res 2023;13(6):2588-2597. (Full text, PDF)
Bashir Lawal, Yu-Cheng Kuo, Alexander TH Wu, Hsu-Shan Huang: Therapeutic potential of EGFR/mTOR/Nf-kb targeting small molecule for the treatment of non-small cell lung cancer. Am J Cancer Res 2023;13(6):2598-2616. (Full text, PDF)
Houliang Zhang, Yifan Zhang, Liu Gao, Wei Song, Haipeng Zhang, Guangcan Yang, Yidi Wang, Jinliang Ni, Keyi Wang, Guangchun Wang, Weipu Mao: Cuproptosis-related LINC01711 promotes the progression of kidney renal clear cell carcinoma. Am J Cancer Res 2023;13(6):2617-2629. (Full text, PDF)
Fa Fang, Yin Gu, Jie Gao, Lili An, Junsheng Kang, Qingshuang Mu, Qin Luo: LINC01354 enhances the metastatic ability of gastric cancer cells by adjusting miR-153-5p/CADM2 expression. Am J Cancer Res 2023;13(6):2630-2643. (Full text, PDF)
Frantzeska Giginis, Joshua Wang, Aaron Chavez, Manuela Martins-Green: Catalase as a novel drug target for metastatic castration-resistant prostate cancer. Am J Cancer Res 2023;13(6):2644-2656. (Full text, PDF)
Hassana El Haddaoui, Casper WF van Eijck, Michail Doukas, Thierry PP van den Bosch, Peter M van Koetsveld, Leo J Hofland, Dana AM Mustafa, Casper HJ van Eijck: Rintatolimod: a potential treatment in patients with pancreatic cancer expressing Toll-like receptor 3. Am J Cancer Res 2023;13(6):2657-2669. (Full text, PDF)
Michelle Xin Liu, Kent-Man Chu: MiR-410-3p suppresses primary gastric cancer and exosomes regulate endogenous expression of miR-410-3p. Am J Cancer Res 2023;13(6):2670-2680. (Full text, PDF)
Xiaohui Jia, Yajuan Zhang, Ting Liang, Yonghao Du, Yanlin Li, Ziyang Mao, Longwen Xu, Yuan Shen, Mengjie Liu, Gang Niu, Hui Guo, Min Jiao: Comprehensive nomogram models for predicting checkpoint inhibitor pneumonitis. Am J Cancer Res 2023;13(6):2681-2701. (Full text, PDF)
Wei Teng, Tai-An Cheng, Po-Ting Lin, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin: Combination of systemic immune-inflammation index and albumin-bilirubin grade predict prognosis of regorafenib in unresectable hepatocellular carcinoma. Am J Cancer Res 2023;13(6):2702-2713. (Full text, PDF)
Jingzhang Li, Kai Sun, Mingming Zhang, Yusheng Luo, Ying Zhang, Cheng Huang, Juanjuan Hong, Dongmei Chen, Wangjun Liao: Long non-coding RNA CYTOR enhances gastric carcinoma proliferation, migration and invasion via the miR-136-5p/HOXC10 axis. Am J Cancer Res 2023;13(6):2714-2731. (Full text, PDF)
Zong-Ying Liang, Zhi-Min Zhang, Guang-Rui Sun, Bao-Shan Zhao, Guo-Hua Xin, Le Zhang: lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis. Am J Cancer Res 2023;13(6):2732-2750. (Full text, PDF)
